Skip to content
Thursday, October 8, 2026
Bold Gamble Market

Social Media Influencers Driving Unofficial Market for Unapproved Weight-Loss Drug

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down violative material and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step guides for mixing or injecting at home.

Within moments of entering one group, a vendor shared WhatsApp details, where most transactions occur. The vendor sent an guidebook and promised shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Details and Costs

Inside these communities, posts display black plastic packages with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to possibly serious medical dangers”.

By

Marco Miller

A financial analyst specializing in high-risk markets, with over a decade of experience in volatile investment strategies.

Bold Gamble Market

Type to search articles.